default author photo

Jung Hun Kang

Gyeongsang National University - Department of Medicine

Chinju City, South Kyongsang

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

1

DOWNLOADS

55

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Randomized, Phase Three, Non-Inferiority Trial

Number of pages: 60 Posted: 09 Aug 2018
Seung Tae Kim, Jung Hun Kang, Jeeyun Lee, Hyun Woo Lee, Sung Young Oh, Joung Soon Jang, Myung Ah Lee, Byeong Seok Sohn, So Young Yoon, Hye Jin Choi, Ji Hyong Hong, Min-Ji Kim, Min-Ji Kim, Seonwoo Kim, Young Suk Park, Joon Oh Park and Ho Yeong Lim
Sungkyunkwan University - Department of Medicine, Gyeongsang National University - Department of Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Ajou University - Department of Medicine, Dong-A University - Department of Medicine, Chung-Ang University, College of Medicine, Department of Medicine, Catholic University of Korea - Department of Medicine, Inje University - Department of Medicine, Konkuk University - Department of Medicine, Yonsei University - Department of Medicine, Catholic University of Korea - Department of Medicine, Sungkyunkwan University - Statistics and Data CenterSungkyunkwan University - Department of Ophthalmology, Sungkyunkwan University - Statistics and Data Center, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine and Sungkyunkwan University - Department of Medicine
Downloads 55 (1,020,567)
Citation 1

Abstract:

Loading...

biliary tract cancer, capecitabine, oxaliplatin, gemcitabine